Exome sequencing of DLBCL samples with PMBL GE signature
Tumor exomes for 15 DLBCL samples with PMBL GE signature, with 6 matching normal exomes and 1 pooled normal exome.
- 22 samples
- DAC: EGAC00000000011
- DS DUO:0000007 (version: 2019-01-07)disease specific researchThis data use permission indicates that use is allowed provided it is related to the specified disease.ModifiersMONDO:0005157
- IRB DUO:0000021 (version: 2019-01-07)ethics approval requiredThis data use modifier indicates that the requestor must provide documentation of local IRB/ERB approval.
- US DUO:0000026 (version: 2019-01-07)user specific restrictionThis data use modifier indicates that use is limited to use by approved users.
PHSA-BC Cancer Policy
This document refers to the data set which has been submitted to the European Genome Archive (EGA) for the controlled access by legitimate academic institutions that have agreed to comply with the terms of a Data Access Agreement drafted by the British Columbia Cancer Agency Branch herein represented by the Technology Development Office of the Provincial Health Services Authority. There are a number of steps that a researcher must take to obtain access to this data and the process is overseen by the Technology Development Office - contact Karen Forrester (karen.forrester@bccancer.ca) or Susan Grose (sgrose@bccancer.bc.ca) or our general email address TDOadmin@phsa.ca
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001005057 | Other |